Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -6 of 6
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
9/1/1995
1.
Phase I/II Study of R-VPAM/DOX for Recurrent Sarcomas (Summary Last Modified 09/95)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II, Phase I
Treatment
Closed
any age
NCI
CCF-IRB-1105
NCI-T94-0167D, T94-0167
Last Modified:
5/3/2007
2.
Phase I/II Study of R-Verapamil with EPOCH (VP-16/PRED/VCR/CTX/DOX), with Analysis of Drug Resistance Mechanisms, in Relapsed/Refractory Lymphomas and Pediatric Sarcomas and of EPOCH Alone in Previously Untreated HIV-Associated Lymphomas (Summary Last Modified 01/96)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II, Phase I
Treatment
Completed
at least 1 year
NCI
NCI-90-C-0113E
NCI-MB-255, NCI-T90-0047N, T90-0047
Last Modified:
6/1/1995
3.
Phase II Study of Paclitaxel with the Multidrug Resistance Modulator Dexverapamil for Metastatic Breast Cancer (Summary Last Modified 06/95)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
18 and over
NCI
TCINJ-940-1529
NCI-T94-0122O, T94-0122
Last Modified:
1/1/1995
4.
Phase II Study of VBL with Dexverapamil for Metastatic Renal Cell Cancer (Summary Last Modified 01/95)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
over 18
MSKCC-91120
NCI-V92-0024
Last Modified:
6/1/1993
5.
Phase II Pilot Study of Continuous-Infusion VIDA (VP-16/IDA/ARA-C) with or without R-Verapamil in Patients with Secondary AML or DeNovo AML in Relapse (Summary Last Modified 06/93)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
18 and over
NCI
NCI-92-C-0241
NCI-MB-296, NCI-T92-0085N, T92-0085
Last Modified:
11/1/1994
6.
Phase I Study of TAX with R-VPAM and G-CSF in Patients with Previously Treated, Metastatic Breast Cancer (Summary Last Modified 11/94)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Completed
18 and over
NCI
NCI-92-C-0245K
NCI-MB-301, NCI-T92-0118N, T92-0118
Select All on One Page
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute